Overview

Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1

Status:
Unknown status
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess potential interactions between intravenous (IV) cocaine and 3 doses of GBR 12909.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Treatments:
Cocaine
Vanoxerine